Contact the Editorial Desk

Editorial correspondence

Peptide Supplied accepts correspondence on the research record: a citation that has been quoted inaccurately, a regulatory status that has changed, or a peer-reviewed study about retatrutide, tesamorelin, or MOTS-c that belongs in the references list. Corrections that improve the factual accuracy of the digest are the most useful messages we receive and are read carefully.

The most actionable notes specify three things: the page in question, the exact passage at issue, and the supporting citation — a DOI or PubMed ID wherever possible. That format lets us verify a proposed change quickly against the source.

Editorial mailbox: editors@peptidesupplied.com

What this desk cannot do

Peptide Supplied is a literature digest — not a clinic, not a pharmacist, and not a vendor. That means we cannot:

• Advise on, recommend, or comment on human use of any peptide discussed here.
• Suggest a dose, schedule, reconstitution method, or route of administration for any individual.
• Diagnose a condition or assess whether a research finding applies to a particular person.
• Sell, source, recommend, or help locate retatrutide, tesamorelin, MOTS-c, or any other compound from any supplier.
• Answer requests from competitive athletes about these compounds, several of which are prohibited in sport.

Readers seeking medical guidance should consult a licensed clinician operating in their own jurisdiction and working with regulated, evidence-based options. Editorial correspondence is monitored intermittently and responses are not guaranteed.